Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk

被引:23
作者
Fargnoli, MC
Edelson, RL
Berger, CL
Chimenti, S
Couture, C
Mustelin, T
Halaban, R
机构
[1] YALE UNIV, SCH MED, DEPT DERMATOL, NEW HAVEN, CT 06520 USA
[2] UNIV AQUILA, I-67100 LAQUILA, ITALY
[3] LA JOLLA INST ALLERGY & IMMUNOL, DIV CELL BIOL, LA JOLLA, CA USA
关键词
phosphoproteins; protein-tyrosine kinase; receptor-CD3; complex; CD45RO(+); protein tyrosine phosphatase;
D O I
10.1038/sj.leu.2400745
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant cells of patients with cutaneous T cell lymphoma (CTCL) are of monoclonal origin and of the CD4(+)/CD45RO(+) subset. Since unlike their normal counterparts, triggering of their TCR/CD3 in vitro elicits only a weak mitogenic response, we set out to determine which of the signal transduction molecules initiated by anti-CD3 epsilon antibodies are affected in neoplastic cells. The results obtained from analysis of tumor cells from four patients show a general reduction in basal and induced tyrosine phosphorylation of a wide range of signaling proteins. Furthermore, the function of members from distinct families of protein tyrosine kinases was altered in neoplastic cells. The enzymatic activity of the membrane-bound fraction of Csk was suppressed, and its association with other cellular proteins was altered. There was a decline in the amount and activity of Syk, and a slight decrease in the specific activity of Lck kinases. Zap70 tyrosyl phosphorylation was reduced or undetectable and the kinase associated weakly, or not at all, with the TCR zeta chain. We propose that dampened TCR-triggered responses in CTCL are caused by suppression of an array of effector molecules required for coupling cell surface receptors to early and late signaling events.
引用
收藏
页码:1338 / 1346
页数:9
相关论文
共 53 条
[21]   COSTIMULATION OF CUTANEOUS T-CELL LYMPHOMA-CELLS BY INTERLEUKIN-7 AND INTERLEUKIN-2 - POTENTIAL AUTOCRINE OR PARACRINE EFFECTORS IN THE SEZARY-SYNDROME [J].
FOSS, FM ;
KOC, Y ;
STETLERSTEVENSON, MA ;
NGUYEN, DT ;
OBRIEN, MC ;
TURNER, R ;
SAUSVILLE, EA .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (02) :326-335
[22]  
HAMAGUCHI I, 1994, ONCOGENE, V9, P3371
[23]   LEUKEMIC T-CELLS FROM PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA DEMONSTRATE ENHANCED ACTIVATION THROUGH CDW60, CD2, AND CD28 RELATIVE TO ACTIVATION THROUGH THE T-CELL ANTIGEN RECEPTOR COMPLEX [J].
HANSEN, ER ;
VEJLSGAARD, GL ;
COOPER, KD ;
HEIDENHEIM, M ;
LARSEN, JK ;
HO, VC ;
ROSS, CW ;
FOX, DA ;
THOMSEN, K ;
BAADSGAARD, O .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (05) :667-673
[24]   SKIN-SELECTIVE LYMPHOCYTE HOMING MECHANISMS IN THE PATHOGENESIS OF LEUKEMIC CUTANEOUS T-CELL LYMPHOMA [J].
HEALD, PW ;
YAN, SL ;
EDELSON, RL ;
TIGELAAR, R ;
PICKER, LJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (02) :222-226
[25]   BE-2 ANTIGEN - APPEARANCE IN ACTIVATION AND LONG-TERM GROWTH OF T-CELLS [J].
HEALD, PW ;
BERGER, CL ;
YAMAMURA, T ;
MCNAMARA, J ;
EDELSON, RL .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 94 (04) :452-455
[26]   CSK SUPPRESSION OF SRC INVOLVES MOVEMENT OF CSK TO SITES OF SRC ACTIVITY [J].
HOWELL, BW ;
COOPER, JA .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (08) :5402-5411
[27]   DISRUPTION OF THE CSK GENE, ENCODING A NEGATIVE REGULATOR OF SRC FAMILY TYROSINE KINASES, LEADS TO NEURAL-TUBE DEFECTS AND EMBRYONIC LETHALITY IN MICE [J].
IMAMOTO, A .
CELL, 1993, 73 (06) :1117-1124
[28]   SIGNALS AND SIGNS FOR LYMPHOCYTE-RESPONSES [J].
JANEWAY, CA ;
BOTTOMLY, K .
CELL, 1994, 76 (02) :275-285
[29]   CTK - A PROTEIN-TYROSINE KINASE RELATED TO CSK THAT DEFINES AN ENZYME FAMILY [J].
KLAGES, S ;
ADAM, D ;
CLASS, K ;
FARGNOLI, J ;
BOLEN, JB ;
PENHALLOW, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2597-2601
[30]   T-CELL ACTIVATION BY CLUSTERED TYROSINE KINASES [J].
KOLANUS, W ;
ROMEO, C ;
SEED, B .
CELL, 1993, 74 (01) :171-183